We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Targacept Announces Designation of Lead Compound in Smoking Cessation Program

News   May 06, 2008

 
Targacept Announces Designation of Lead Compound in Smoking Cessation Program
 
 
Advertisement
 

RELATED ARTICLES

Team Develops Synthetic Blood-Thinner With No Bleeding Side Effects

News

Scientists have developed a highly selective and highly stable synthetic blood-thinning molecule that, unlike others, doesn’t cause bleeding adverse effects.

READ MORE

Wuhan COVID-19 Vaccine Trials Show Early Positive Results, Moving Forward to Phase 3 Testing

News

The adenovirus type-5-vectored COVID-19 vaccine was shown to be safe and induced significant immune responses in the majority of recipients after a single immunization.

READ MORE

Oxford Coronavirus Vaccine Produces Strong Immune Response, Early Results Indicate

News

A team of scientists at Oxford University has taken the next step towards the discovery of a safe, effective and accessible vaccine against coronavirus.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE